December 1st, 2011
Meta-Analysis Finds Benefits for Self-Monitoring in Some Warfarin Patients
Larry Husten, PHD
Despite the advent of newer anticoagulants that don’t require monitoring, millions of people will continue to take warfarin for many years to come. Now a new meta-analysis published in the Lancet suggests that some of these patients may benefit from self-monitoring. Carl Heneghan and colleagues analyzed data from 11 trials with 6417 patients on oral anticoagulation and 12,800 person-years […]
October 21st, 2010
INR Home Testing Found Comparable to Point-of-Care Testing
Larry Husten, PHD
Weekly INR self-testing at home is comparable to monthly point-of-care testing, according to results of THINRS (the Home International Normalized Ratio Study), published in the New England Journal of Medicine. David Matchar and colleagues found no difference in the incidence of stroke, major bleeding episode, or death in the 2922 patients taking warfarin who were randomized to […]
NEJM Journal Watch — Recent Cardiology Articles- Atorvastatin vs. Rosuvastatin: Do Effectiveness and Safety Differ?
- Which Patients with Cardiogenic Shock Are at Risk for Early Death?
- Cardiac Magnetic Resonance Imaging for Risk Stratification in Nonischemic Cardiomyopathy
- Evidence Mounts for Triple Single-Pill Combination Therapy for Hypertension
- Atherosclerosis Burden and Progression on Imaging and Associated Mortality in Asymptomatic Patients